BXP
39
-8
LNC
22
-7
ES
7
-7
AEP
39
-4
UNM
62
-8
EIX
53
-8
GOOGL
58
-8
VFC
54
-7
FMC
17
-6
MUR
38
-4
NEM
34
-8
RL
65
-7
MS
59
-9
NWS
62
-7
VRSN
55
-2
INTU
53
-8
PG
40
-3
TDC
65
-10
OI
23
-2
NWSA
65
-8
BXP
39
-8
LNC
22
-7
ES
7
-7
AEP
39
-4
UNM
62
-8
EIX
53
-8
GOOGL
58
-8
VFC
54
-7
FMC
17
-6
MUR
38
-4
NEM
34
-8
RL
65
-7
MS
59
-9
NWS
62
-7
VRSN
55
-2
INTU
53
-8
PG
40
-3
TDC
65
-10
OI
23
-2
NWSA
65
-8
Financhill
Back

SPDR Portfolio Intermediate Term Corporate Bd ETF Vs. Viking Therapeutics Industry Stock Comparison

Sell
47

SPIB
SPDR Portfolio Intermediate Term Corporate Bd ETF

Last Price:
32.67
Seasonality Move:
-0.27%
Sell
28

VKTX
Viking Therapeutics

Last Price:
41.12
Seasonality Move:
40.87%
Sell
47
SPDR Portfolio Intermediate Term Corporate Bd ETF (SPIB) is a Sell

Is SPDR Portfolio Intermediate Term Corporate Bd ETF a Buy, Sell or Hold?

  • The current SPDR Portfolio Intermediate Term Corporate Bd ETF [SPIB] share price is $32.82. The Score for SPIB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • SPIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPIB Stock Price Chart

What is SPDR Portfolio Intermediate Term Corporate Bd ETF's stock price today?

  • The SPDR Portfolio Intermediate Term Corporate Bd ETF share price today is $32.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPIB is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $38.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

SPIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 34.05 Sell
Chaikin Money Flow: -6103889 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.94 - 33.2) Sell
Bollinger Bands (100): (33.02 - 33.54) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.91 Sell
Relative Strength Index (14 RSI): 23.24 Sell
Chaikin Money Flow: -10764092 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.91 - 53.55) Sell
Bollinger Bands (100): (52.21 - 67.17) Sell

SPIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.08 Sell
20-day SMA: 33.1 Sell
50-day SMA: 33.11 Sell
200-day SMA: 32.89 Sell
8-day EMA: 33.04 Sell
20-day EMA: 33.08 Sell
50-day EMA: 33.13 Sell
200-day EMA: 32.94 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.82 Sell
20-day SMA: 49.84 Sell
50-day SMA: 58.67 Sell
200-day SMA: 62.24 Sell
8-day EMA: 46.02 Sell
20-day EMA: 49.86 Sell
50-day EMA: 55.23 Sell
200-day EMA: 54.61 Sell

SPDR Portfolio Intermediate Term Corporate Bd ETF Earnings Growth & SPIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

SPDR Portfolio Intermediate Term Corporate Bd ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):